ACADIA Pharmaceuticals Inc (ACAD.O)

ACAD.O on Nasdaq

40.19USD
28 May 2015
Change (% chg)

-- (--)
Prev Close
$40.19
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,085,336
52-wk High
$46.48
52-wk Low
$19.21

ACAD.O

Chart for ACAD.O

About

ACADIA Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in neurological and related central nervous system disorders. It has a pipeline of product candidates led by NUPLAZID (pimavanserin), which is in Phase III development as... (more)

Overall

Beta: 3.08
Market Cap(Mil.): $4,030.95
Shares Outstanding(Mil.): 100.30
Dividend: --
Yield (%): --

Financials

  ACAD.O Industry Sector
P/E (TTM): -- 303.02 38.01
EPS (TTM): -1.15 -- --
ROI: -35.35 -5.79 15.44
ROE: -35.36 -6.75 16.48
Search Stocks

Acadia delays U.S. application to market lead drug, CEO retires

- Acadia Pharmaceuticals Inc said it had delayed submitting a U.S. marketing application for its lead drug, nuplazid, and that its chief executive was retiring.

11 Mar 2015

UPDATE 1-Acadia delays U.S. application to market lead drug, CEO retires

March 11 - Acadia Pharmaceuticals Inc said it had delayed submitting a U.S. marketing application for its lead drug, nuplazid, and that its chief executive was retiring.

11 Mar 2015

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00
Provider: Pechala's Reports
$1,000.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks